Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Alport Syndrome
NCT05655728Phase 4Unknown
- Sponsor
- Peking University First Hospital
- Start
- Jan 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of metformin in Alport syndrome, sponsored by Peking University First Hospital. Status: unknown.
02
Drugs
metformin
03
Conditions
Alport syndrome
Beyond the preview
Go deeper on NCT05655728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05655728.